<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Satoyoshi Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-name-link {
            color: inherit;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
        }

        .item-name-link:hover {
            text-decoration-thickness: 2px;
        }

        .missing-disease-name {
            color: #991b1b;
            border-bottom: 1px dotted #dc2626;
        }

        .curation-gap-badge {
            display: inline-flex;
            align-items: center;
            margin-left: 8px;
            padding: 2px 8px;
            border-radius: 999px;
            font-size: 0.72rem;
            font-weight: 700;
            letter-spacing: 0.01em;
            text-transform: uppercase;
            background: #fef2f2;
            border: 1px solid #fecaca;
            color: #b91c1c;
            vertical-align: middle;
        }

        .missing-ontology-link {
            color: #b91c1c !important;
            text-decoration: underline dotted;
            text-underline-offset: 2px;
        }

        .dismech-inline-link {
            margin-left: 6px;
            font-size: 0.78rem;
            font-weight: 600;
            color: #0369a1;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
            white-space: nowrap;
        }

        .dismech-inline-link:hover {
            text-decoration-thickness: 2px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "â†³ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Satoyoshi Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Satoyoshi Syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Autoimmune</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0010922" target="_blank">
                        MONDO:0010922
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Autoimmune Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Rare Disease</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                A rare multisystem disorder characterized by progressive painful muscle spasms, alopecia (often progressing to alopecia universalis), chronic diarrhea with malabsorption, and skeletal abnormalities. Amenorrhea is common in affected females. An autoimmune basis is presumed based on the frequent presence of autoantibodies, inflammatory tissue infiltrates, and response to immunosuppressive therapy. Approximately 73% of reported cases are female, with median onset around age 11 and median age at diagnosis of 16 years. Most cases have been reported from Japan.
            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
            
                
            
        
        <div class="stats-bar">
            
            <a class="stat-link" href="#mappings">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Mappings</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#definitions">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Definitions</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#histopathology">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Histopathology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">10</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        
        <div class="card" id="mappings">
            <div class="card-header">
                <div class="card-icon" style="background: #e0f2fe; color: #0369a1;">ðŸ”—</div>
                <h2 class="card-title">Mappings</h2>
            </div>
            
            <div class="mapping-section">
                <div class="classification-category">MONDO</div>
                
                
                
                
                <div class="mapping-item">
                    <div class="mapping-title">
                        
                        <a href="http://purl.obolibrary.org/obo/MONDO_0010922" target="_blank">MONDO:0010922</a>
                        
                        
                        <span class="mapping-label">Satoyoshi syndrome</span>
                        
                        
                        
                    </div>
                    <div class="tag-list">
                        
                        <span class="tag tag-classification">skos:exactMatch</span>
                        
                        
                        <span class="tag tag-parent">MONDO</span>
                        
                        
                    </div>
                    
                    <div class="mapping-notes">Primary MONDO disease term for this entry.</div>
                    
                </div>
                
            </div>
            
            
            
        </div>
        

        <!-- Definitions -->
        
        <div class="card" id="definitions">
            <div class="card-header">
                <div class="card-icon" style="background: #cffafe; color: #0e7490;">ðŸ“˜</div>
                <h2 class="card-title">Definitions</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box definition-box">
                <div class="item-name">Literature case definition for Satoyoshi syndrome</div>
                
                <div class="item-desc">Case-level definition synthesized from systematic reviews, centered on the characteristic triad with multisystem supportive features and autoimmune context.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-classification">CASE_DEFINITION</span>
                    
                    
                    <span class="tag tag-parent">Published case reports and case series</span>
                    
                </div>
                
    
    
                
    
    
                
    
    
                
    
    
                
    
    
                
    
    
                
                
                <div class="criteria-block">
                    <div class="criteria-title">Core clinical triad</div>
                    
                    <div class="item-desc">Characteristic high-yield symptom cluster for case recognition.</div>
                    
                    
                    <div class="criteria-meta">
                        
                        
                        Minimum required: 2
                    </div>
                    
                    
    
    <div class="criteria-group">
        <div class="criteria-header">Core clinical characteristics</div>
        <ul class="criteria-list">
            
            <li>
                <span class="criteria-term">Intermittent painful muscle spasms</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Alopecia</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Chronic diarrhea</span>
                
            </li>
            
        </ul>
    </div>
    
    
                    
    
    
                    
    
    
                    
    
    
                    
    
    
                    
    
    
                    
    
    
                    
                </div>
                
                <div class="criteria-block">
                    <div class="criteria-title">Multisystem supportive manifestations</div>
                    
                    <div class="item-desc">Frequent associated findings that strengthen diagnostic confidence.</div>
                    
                    
                    <div class="criteria-meta">
                        
                        
                        Minimum required: 1
                    </div>
                    
                    
    
    
                    
    
    <div class="criteria-group">
        <div class="criteria-header">Inclusion criteria</div>
        <ul class="criteria-list">
            
            <li>
                <span class="criteria-term">Malabsorption</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Secondary amenorrhea</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Abnormality of the skeletal system</span>
                
            </li>
            
        </ul>
    </div>
    
    
                    
    
    <div class="criteria-group">
        <div class="criteria-header">Exclusion criteria</div>
        <ul class="criteria-list">
            
            <li>
                <span class="criteria-term">Alternative causes of painful muscle spasms and chronic diarrhea excluded</span>
                
            </li>
            
        </ul>
    </div>
    
    
                    
    
    
                    
    
    
                    
    
    
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">This supports the core triad-plus-skeletal pattern used for case definition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All cases had painful muscular spasms and alopecia."</div>
                
                
                <div class="evidence-explanation">Universal occurrence of spasms and alopecia supports high-weight core criteria.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Frequent manifestations included: diarrhoea, malabsorption, growth retardation, amenorrhoea and bone deformity."</div>
                
                
                <div class="evidence-explanation">This supports inclusion of multisystem supportive criteria.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                
            </div>
            
        </div>
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">âš™</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Systemic Autoimmune Activation</div>
                
                <div class="item-desc">Satoyoshi syndrome shows systemic immune activation with circulating ANA and other autoantibodies in a substantial subset of cases.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Lymphocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000542" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Plasma Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000786" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        B Cell Mediated Immunity
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019724" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Adaptive Immune Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002250" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Antinuclear antibodies were detected in 8 out of 16 cases. Antibodies to stomach or duodenum tissue lysates were also detected by Western blot."</div>
                
                
                <div class="evidence-explanation">Detection of ANA and additional tissue-reactive antibodies supports systemic autoimmunity as an upstream disease event.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Autoantibody determinations were performed in 39 patients, of which 27 had positive results. The most frequently detected autoantibodies were ANAs."</div>
                
                
                <div class="evidence-explanation">This broader systematic review confirms frequent autoantibody positivity and ANA predominance, reinforcing systemic autoimmune activation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28940615" target="_blank">PMID:28940615</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"It is a rare multisystem disorder of presumed autoimmune etiology that is characterized by alopecia, intermittent painful muscle spasms, diarrhea, and antinuclear antibody positivity."</div>
                
                
                <div class="evidence-explanation">Independent case-report abstract supports autoimmune etiology and ANA positivity in Satoyoshi syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Tissue-Reactive Autoantibody Production</div>
                
                <div class="item-desc">Western blot studies identified circulating antibodies that react with brain, stomach, and duodenal tissue lysates, consistent with a shared tissue-targeted autoimmune response.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17405137" target="_blank">PMID:17405137</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A common antibody against brain, stomach, and duodenal tissue, according to Western blot analysis, was detected in the sera of two patients with this syndrome. These findings suggest that Satoyoshi syndrome is a systemic autoimmune disease involving the nervous, endocrine, and gastrointestinal systems."</div>
                
                
                <div class="evidence-explanation">This report directly demonstrates tissue-reactive antibodies spanning nervous and gastrointestinal systems.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Antibodies to stomach or duodenum tissue lysates were also detected by Western blot."</div>
                
                
                <div class="evidence-explanation">Independent systematic-review evidence reproduces gastrointestinal tissue-reactive antibody detection.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuromuscular Circuit Dysfunction</div>
                
                <div class="item-desc">Immune-mediated dysfunction of motor circuitry and neuromuscular signaling is a plausible proximal mechanism for abnormal muscle activation.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Skeletal Muscle Fiber
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000187" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Regulation of Muscle Contraction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006937" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Neuromuscular Transmission
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007274" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome is a multisystemic rare disease of unknown etiology, although an autoimmune basis is presumed. Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Systematic review of 64 cases confirms painful muscle spasms as a universal feature, with autoimmune basis presumed but specific neuromuscular mechanism not yet resolved.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16972238" target="_blank">PMID:16972238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"These findings point to hyperactivity or a disinhibition at the alpha motor neuron level, originating probably at that level, although a central origin cannot be excluded."</div>
                
                
                <div class="evidence-explanation">Electrophysiologic data support alpha motor neuron hyperexcitability as a proximal mechanism for painful involuntary contractions.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16972238" target="_blank">PMID:16972238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"During the involuntary contractions, HD-sEMG showed a fourfold increase in amplitude compared to maximal voluntary contractions."</div>
                
                
                <div class="evidence-explanation">Objective EMG amplitude amplification supports abnormal neuromuscular circuit excitability as a proximal event.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Gastrointestinal Mucosal Inflammation</div>
                
                <div class="item-desc">Histology shows predominantly lymphoplasmacytic inflammatory infiltrates across the digestive tract.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Lymphocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000542" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Plasma Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000786" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Inflammatory Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Histological data revealed predominantly lymphoplasmacytic inflammatory infiltrate that can affect any section of the digestive tract."</div>
                
                
                <div class="evidence-explanation">Histological evidence confirms inflammatory infiltration of the GI tract consistent with autoimmune-mediated enteropathy.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17405137" target="_blank">PMID:17405137</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We present a patient with this syndrome having a unique &#34;mesh-like&#34; mucosal change radiographically and white granules endoscopically in the gastrointestinal tract."</div>
                
                
                <div class="evidence-explanation">Independent endoscopic/radiographic mucosal abnormalities further support GI tissue pathology in Satoyoshi syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Intestinal Absorptive Dysfunction</div>
                
                <div class="item-desc">Carbohydrate malabsorption is demonstrated by abnormal D-xylose and oral glucose tolerance testing.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Intestinal Absorption
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0050892" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        â†“ DECREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic diarrhea was the main digestive symptom (92.3%). Other symptoms such as abdominal pain (15.4%), nausea (7.7%) and vomiting (7.7%), were less frequent. The D-xylose test was positive in 10 out of 12 patients, and 9 out of 13 cases showed a flattened oral glucose tolerance test suggesting..."</div>
                
                
                <div class="evidence-explanation">Clinical testing demonstrates carbohydrate malabsorption and its close association with chronic diarrhea.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic diarrhea may be severe and result in malnutrition, anemia, growth retardation, cachexia, disability and even death."</div>
                
                
                <div class="evidence-explanation">This links prolonged gastrointestinal dysfunction to downstream growth consequences.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic diarrhea with malabsorption is one of the most disabling symptoms in SS."</div>
                
                
                <div class="evidence-explanation">This conclusion-level statement directly supports clinically significant absorptive dysfunction.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hair Follicle Immune Injury</div>
                
                <div class="item-desc">Autoimmune targeting of follicular units is a plausible mechanism for the characteristic diffuse hair loss phenotype.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Immune Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome is a multisystemic rare disease of unknown etiology, although an autoimmune basis is presumed. Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Systematic review confirms alopecia as one of the main symptoms present in 100% of reported cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All cases had painful muscular spasms and alopecia."</div>
                
                
                <div class="evidence-explanation">The larger 77-case review confirms alopecia as a universal feature, supporting an upstream follicular injury mechanism.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        
        <div class="card" id="histopathology">
            <div class="card-header">
                <div class="card-icon" style="background: #ffedd5; color: #c2410c;">âœ¶</div>
                <h2 class="card-title">Histopathology</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box histopathology-box">
                <div class="item-name">
                    Gastrointestinal lymphoplasmacytic inflammatory infiltrate
                    
                    <span class="histopathology-freq">FREQUENT</span>
                    
                </div>
                
                <div class="item-desc">Digestive tract histology shows predominantly lymphoplasmacytic inflammatory infiltrates, consistent with inflammatory enteropathy.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Histological data revealed predominantly lymphoplasmacytic inflammatory infiltrate that can affect any section of the digestive tract."</div>
                
                
                <div class="evidence-explanation">This directly supports a characteristic microscopic inflammatory finding in Satoyoshi syndrome gastrointestinal disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box histopathology-box">
                <div class="item-name">
                    Gastrointestinal mucosal structural abnormalities
                    
                    <span class="histopathology-freq">OCCASIONAL</span>
                    
                </div>
                
                <div class="item-desc">Reported gastrointestinal pathology includes diffuse mucosal structural abnormalities seen on radiographic and endoscopic assessment.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17405137" target="_blank">PMID:17405137</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We present a patient with this syndrome having a unique &#34;mesh-like&#34; mucosal change radiographically and white granules endoscopically in the gastrointestinal tract."</div>
                
                
                <div class="evidence-explanation">This supports additional gastrointestinal tissue-level pathology beyond the inflammatory infiltrate pattern.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">â¬¡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Neuromuscular_Circuit_Dysfunction[&#34;Neuromuscular Circuit Dysfunction&#34;]
    Gastrointestinal_Mucosal_Inflammation[&#34;Gastrointestinal Mucosal Inflammation&#34;]
    Intestinal_Absorptive_Dysfunction[&#34;Intestinal Absorptive Dysfunction&#34;]
    Short_Stature[&#34;Short Stature&#34;]
    Systemic_Autoimmune_Activation[&#34;Systemic Autoimmune Activation&#34;]
    Tissue_Reactive_Autoantibody_Production[&#34;Tissue-Reactive Autoantibody Production&#34;]
    Painful_Muscle_Spasms[&#34;Painful Muscle Spasms&#34;]
    Chronic_Diarrhea[&#34;Chronic Diarrhea&#34;]
    Alopecia[&#34;Alopecia&#34;]
    Hair_Follicle_Immune_Injury[&#34;Hair Follicle Immune Injury&#34;]
    Malabsorption[&#34;Malabsorption&#34;]

    Systemic_Autoimmune_Activation --&gt; Tissue_Reactive_Autoantibody_Production
    Tissue_Reactive_Autoantibody_Production --&gt; Neuromuscular_Circuit_Dysfunction
    Tissue_Reactive_Autoantibody_Production --&gt; Gastrointestinal_Mucosal_Inflammation
    Tissue_Reactive_Autoantibody_Production --&gt; Hair_Follicle_Immune_Injury
    Neuromuscular_Circuit_Dysfunction --&gt; Painful_Muscle_Spasms
    Gastrointestinal_Mucosal_Inflammation --&gt; Intestinal_Absorptive_Dysfunction
    Intestinal_Absorptive_Dysfunction --&gt; Malabsorption
    Intestinal_Absorptive_Dysfunction --&gt; Chronic_Diarrhea
    Intestinal_Absorptive_Dysfunction --&gt; Short_Stature
    Hair_Follicle_Immune_Injury --&gt; Alopecia

    style Neuromuscular_Circuit_Dysfunction fill:#dbeafe
    style Gastrointestinal_Mucosal_Inflammation fill:#dbeafe
    style Intestinal_Absorptive_Dysfunction fill:#dbeafe
    style Short_Stature fill:#fef3c7
    style Systemic_Autoimmune_Activation fill:#dbeafe
    style Tissue_Reactive_Autoantibody_Production fill:#dbeafe
    style Painful_Muscle_Spasms fill:#fef3c7
    style Chronic_Diarrhea fill:#fef3c7
    style Alopecia fill:#fef3c7
    style Hair_Follicle_Immune_Injury fill:#dbeafe
    style Malabsorption fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">â—</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">10</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Digestive<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Integument<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Musculoskeletal<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Constitutional<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Growth<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-7">Other<span class="pill-count">(2)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Diarrhea
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002028" target="_blank">
                                Chronic diarrhea
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002028)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Present in 92.3% of cases with GI involvement; can be fatal</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic diarrhea was the main digestive symptom (92.3%)."</div>
                
                
                <div class="evidence-explanation">Systematic review identifies chronic diarrhea as the predominant GI symptom in 92.3% of cases with gastrointestinal manifestations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Frequent manifestations included: diarrhoea, malabsorption, growth retardation, amenorrhoea and bone deformity."</div>
                
                
                <div class="evidence-explanation">Broader case synthesis also classifies diarrhoea as a frequent Satoyoshi manifestation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28267828" target="_blank">PMID:28267828</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal deformities."</div>
                
                
                <div class="evidence-explanation">Case history report independently documents chronic diarrhea among multisystem Satoyoshi manifestations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Malabsorption
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002024" target="_blank">
                                Malabsorption
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002024)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">D-xylose and oral glucose tolerance tests demonstrate carbohydrate malabsorption</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The D-xylose test was positive in 10 out of 12 patients, and 9 out of 13 cases showed a flattened oral glucose tolerance test suggesting carbohydrate malabsorption."</div>
                
                
                <div class="evidence-explanation">Objective malabsorption testing demonstrates carbohydrate malabsorption in the majority of tested patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Frequent manifestations included: diarrhoea, malabsorption, growth retardation, amenorrhoea and bone deformity."</div>
                
                
                <div class="evidence-explanation">Independent systematic review evidence confirms malabsorption as a frequent manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Uveitis
                        
                        <span class="phenotype-freq">VERY_RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000554" target="_blank">
                                Uveitis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000554)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Newly reported complication (2023); granulomatous pan-uveitis with impending CRVO</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36930111" target="_blank">PMID:36930111</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Unilateral granulomatous pan-uveitis and impending CRVO were observed in this patient. Several cases of Satoyoshi syndrome complicated by various autoimmune or immunological disorders have been reported. However, to the best of our knowledge, no reports of Satoyoshi syndrome presenting with..."</div>
                
                
                <div class="evidence-explanation">First reported case of uveitis in Satoyoshi syndrome, expanding the known organ spectrum of the disease and supporting systemic autoimmune pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Integument
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Alopecia
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001596" target="_blank">
                                Alopecia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001596)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Alopecia reported in 100% of cases across systematic reviews</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All cases had painful muscular spasms and alopecia."</div>
                
                
                <div class="evidence-explanation">The largest systematic review (77 cases) reports alopecia as universal in Satoyoshi syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome is a multisystemic rare disease of unknown etiology, although an autoimmune basis is presumed. Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Independent systematic review (64 cases) also identifies alopecia as a core syndrome feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Painful Muscle Spasms
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0011964" target="_blank">
                                Intermittent painful muscle spasms
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0011964)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Progressive, painful intermittent spasms (komuragaeri) especially of limbs and trunk; present in 100% of cases</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome is a multisystemic rare disease of unknown etiology, although an autoimmune basis is presumed. Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Painful muscle spasms are listed as one of the cardinal symptoms in this systematic review of 64 cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All cases had painful muscular spasms and alopecia."</div>
                
                
                <div class="evidence-explanation">Independent 77-case review confirms painful spasms as a universal phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9804090" target="_blank">PMID:9804090</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome consists of painful intermittent muscle spasms, alopecia and diarrhea."</div>
                
                
                <div class="evidence-explanation">Adult-onset review independently confirms painful intermittent spasms as a core phenotype.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Skeletal Abnormalities
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000924" target="_blank">
                                Abnormality of the skeletal system
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000924)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Skeletal alterations reported in approximately 34% of cases</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Skeletal abnormalities are listed as one of the main symptoms in this systematic review of 64 cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15069249" target="_blank">PMID:15069249</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome (Komuragaeri disease) is a rare disorder of presumed autoimmune etiology, characterized by painful muscle spasms, alopecia, diarrhea, endocrinopathy with amenorrhoea and secondary skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Independent case literature explicitly reports secondary skeletal abnormalities as part of the syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28267828" target="_blank">PMID:28267828</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal deformities."</div>
                
                
                <div class="evidence-explanation">Independent case evidence supports skeletal deformities as part of the phenotype spectrum.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Abdominal Pain
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002027" target="_blank">
                                Abdominal pain
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002027)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Other symptoms such as abdominal pain (15.4%), nausea (7.7%) and vomiting (7.7%), were less frequent."</div>
                
                
                <div class="evidence-explanation">Abdominal pain reported in 15.4% of cases with gastrointestinal involvement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Growth
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Short Stature
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0004322" target="_blank">
                                Short stature
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0004322)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Common in pediatric cases, plausibly secondary to malabsorption and chronic inflammation</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic diarrhea may be severe and result in malnutrition, anemia, growth retardation, cachexia, disability and even death."</div>
                
                
                <div class="evidence-explanation">Growth retardation is listed as a consequence of severe chronic diarrhea and malabsorption in Satoyoshi syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Frequent manifestations included: diarrhoea, malabsorption, growth retardation, amenorrhoea and bone deformity."</div>
                
                
                <div class="evidence-explanation">Systematic review independently confirms growth retardation as a frequent manifestation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-7">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Alopecia Universalis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002289" target="_blank">
                                Alopecia universalis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002289)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Universalis subtype reported in approximately 63% of cases</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36930111" target="_blank">PMID:36930111</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"At the age of 7 years, she developed generalized hair loss and painful spasms and was diagnosed with Satoyoshi syndrome."</div>
                
                
                <div class="evidence-explanation">Case report documents generalized hair loss as a presenting feature of Satoyoshi syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28940615" target="_blank">PMID:28940615</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report an 11-year-old girl with Satoyoshi syndrome who presented to the dermatology department for treatment of alopecia universalis."</div>
                
                
                <div class="evidence-explanation">Case report directly documents alopecia universalis as a presenting phenotype.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Amenorrhea
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000869" target="_blank">
                                Secondary amenorrhea
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000869)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Secondary amenorrhea in affected females</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36749015" target="_blank">PMID:36749015</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Frequent manifestations included: diarrhoea, malabsorption, growth retardation, amenorrhoea and bone deformity."</div>
                
                
                <div class="evidence-explanation">Systematic review of 77 cases identifies amenorrhoea as one of the frequent manifestations of Satoyoshi syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15069249" target="_blank">PMID:15069249</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome (Komuragaeri disease) is a rare disorder of presumed autoimmune etiology, characterized by painful muscle spasms, alopecia, diarrhea, endocrinopathy with amenorrhoea and secondary skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Independent case report abstract explicitly includes amenorrhoea in the characteristic syndrome phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28267828" target="_blank">PMID:28267828</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal deformities."</div>
                
                
                <div class="evidence-explanation">Additional case evidence directly supports amenorrhea in Satoyoshi syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">ðŸ§¬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    No established monogenic etiology
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Unknown)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Satoyoshi syndrome is a multisystemic rare disease of unknown etiology, although an autoimmune basis is presumed."</div>
                
                
                <div class="evidence-explanation">This review explicitly states that disease etiology remains unknown.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16972238" target="_blank">PMID:16972238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Although an autoimmune origin of Satoyoshi syndrome seems likely, its exact etiology remains as yet unknown, as is the origin of the involuntary contractions."</div>
                
                
                <div class="evidence-explanation">Electrophysiology-focused case study confirms unresolved etiology despite autoimmune evidence.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">ðŸ’Š</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Corticosteroids
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000640" target="_blank">
                            MAXO:0000640
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">First-line treatment with the best overall results. 28 out of 30 cases responded to a regimen that included corticosteroids. Corticosteroid-containing regimens improved diarrhea in 6 out of 10 patients with GI involvement. None of the three patients who died had received corticosteroids or immunosuppressants.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"28 out of 30 cases responded to a regimen that included costicosteroids."</div>
                
                
                <div class="evidence-explanation">Systematic review demonstrates that corticosteroid-containing regimens produced favorable responses in the large majority of treated cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In 6 out of 10 patients, diarrhea improved with a treatment regimen that included corticosteroids."</div>
                
                
                <div class="evidence-explanation">Corticosteroid-containing regimens specifically improved gastrointestinal symptoms, supporting the inflammatory/autoimmune basis of the enteropathy.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"None of the three patients who died had received corticosteroids or immunosuppressants."</div>
                
                
                <div class="evidence-explanation">The observation that all fatal cases lacked immunosuppressive treatment suggests corticosteroids may reduce mortality, though publication bias must be considered.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Dantrolene
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000324" target="_blank">
                            MAXO:0000324
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Muscle relaxant that improved muscle symptoms in 13 out of 15 cases, but did not improve any other symptoms of the disease. Used for symptomatic management of painful spasms.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Dantrolene improved muscle symptoms in 13 out of 15 cases, but not any other symptoms of the disease."</div>
                
                
                <div class="evidence-explanation">Dantrolene is effective for muscle spasm control but does not address the underlying autoimmune process or other systemic manifestations.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Immunosuppressive Agents
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Various immunosuppressants including cyclosporine, mycophenolate mofetil, azathioprine, methotrexate, tacrolimus, and cyclophosphamide have been used as steroid-sparing agents or to improve efficacy of treatment.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Other immunosuppressive drugs including cyclosporine, mycophenolate mofetil, azathioprine, methotrexate, tacrolimus and cyclophosphamide were used to decrease corticosteroid dose or improve efficacy."</div>
                
                
                <div class="evidence-explanation">Multiple immunosuppressive agents have been employed as steroid-sparing therapy in Satoyoshi syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Intravenous Immunoglobulin (IVIG)
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Used in some cases with variable response. Four out of nine patients treated with IVIG obtained a favorable response.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Immunoglobulin therapy was used in nine patients and four of them obtained a favorable response."</div>
                
                
                <div class="evidence-explanation">IVIG produced favorable responses in less than half of treated patients, indicating variable efficacy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">ðŸ”¬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Antinuclear Antibodies (ANA)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Variable)</span>
                    
                </div>
                
                <div class="item-desc">Context: Most commonly detected autoantibody; found in 8/16 GI-series cases and 21/39 in autoimmunity review</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32429959" target="_blank">PMID:32429959</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Antinuclear antibodies were detected in 8 out of 16 cases."</div>
                
                
                <div class="evidence-explanation">ANA are the most frequently detected autoantibody in Satoyoshi syndrome patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Anti-Brain and GI Tissue Antibodies
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Positive)</span>
                    
                </div>
                
                <div class="item-desc">Context: Circulating antibodies targeting a ~90 kDa antigen in brain, stomach, and duodenal lysates</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17405137" target="_blank">PMID:17405137</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A common antibody against brain, stomach, and duodenal tissue, according to Western blot analysis, was detected in the sera of two patients with this syndrome."</div>
                
                
                <div class="evidence-explanation">Western blot demonstrates a shared tissue-reactive autoantibody in Satoyoshi syndrome sera, supporting a common autoantigen across nervous and gastrointestinal systems.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">ðŸ”€</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">2</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Satoyoshi Syndrome:
            </p>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Classic stiff person syndrome</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0018625" target="_blank" class="missing-ontology-link">
                            MONDO:0018625
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Both disorders can present with painful muscle spasms, but classic stiff person syndrome is defined by prominent persistent body stiffness and characteristic axial involvement.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Typical SPS presentation includes generalized body stiffness and exaggerated lumbar lordosis.</li>
                        
                        <li>Satoyoshi syndrome instead has obligate alopecia and frequent chronic diarrhea/malabsorption.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23186907" target="_blank">PMID:23186907</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"It is uncommon, characterized by body stiffness associated with painful muscle spasms, and varies in location and severity."</div>
                
                
                <div class="evidence-explanation">Confirms the painful spasm overlap and defining stiffness phenotype of SPS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23186907" target="_blank">PMID:23186907</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Most patients demonstrate exaggerated lumbar lordosis."</div>
                
                
                <div class="evidence-explanation">Lumbar lordosis is a characteristic SPS feature that helps distinguish it from Satoyoshi syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31217029" target="_blank">PMID:31217029</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Its main symptoms are: painful muscle spasms, diarrhea, alopecia and skeletal abnormalities."</div>
                
                
                <div class="evidence-explanation">Satoyoshi-specific multisystem features (especially alopecia and diarrhea) help distinguish it from SPS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Isaac syndrome</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0019399" target="_blank" class="missing-ontology-link">
                            MONDO:0019399
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Both disorders can involve painful cramps/spasms, but Isaac syndrome is a peripheral nerve hyperexcitability disorder with continuous motor activity and characteristic myokymia/fasciculations.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Continuous motor activity with fasciculations and myokymia suggests Isaac syndrome.</li>
                        
                        <li>Electrodiagnostic after-discharges and neuromyotonic/myokymic discharges are typical for Isaac syndrome.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25736532" target="_blank">PMID:25736532</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Isaacs syndrome is a peripheral nerve hyperexcitability (PNH) syndrome that presents as continuous motor activity. Clinical findings include cramps, fasciculations, and myokymia."</div>
                
                
                <div class="evidence-explanation">This defines key clinical features that separate Isaac syndrome from the broader multisystem Satoyoshi phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25736532" target="_blank">PMID:25736532</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Electrodiagnosis plays a key role in diagnosis by demonstrating after-discharges on nerve conduction studies, and fasciculation potentials, myokymic discharges, neuromyotonic discharges, and other types of abnormal spontaneous activity on needle examination."</div>
                
                
                <div class="evidence-explanation">Characteristic electrodiagnostic findings provide a key differentiator from Satoyoshi syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Satoyoshi Syndrome
creation_date: &#34;2026-02-23T00:00:00Z&#34;
updated_date: &#34;2026-02-24T19:00:18Z&#34;
category: Autoimmune
synonyms:
- Komuragaeri disease
parents:
- Autoimmune Disease
- Rare Disease
disease_term:
  preferred_term: Satoyoshi syndrome
  term:
    id: MONDO:0010922
    label: Satoyoshi syndrome
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0010922
      label: Satoyoshi syndrome
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: Primary MONDO disease term for this entry.
    notes: &gt;-
      PMID:32429959 reports external cross-references OMIM:600705 and ORPHA:3130.
      The current schema does not yet expose dedicated OMIM/ORPHA mapping slots.
description: &gt;-
  A rare multisystem disorder characterized by progressive painful muscle spasms,
  alopecia (often progressing to alopecia universalis), chronic diarrhea with
  malabsorption, and skeletal abnormalities. Amenorrhea is common in affected
  females. An autoimmune basis is presumed based on the frequent presence of
  autoantibodies, inflammatory tissue infiltrates, and response to immunosuppressive
  therapy. Approximately 73% of reported cases are female, with median onset
  around age 11 and median age at diagnosis of 16 years. Most cases have been
  reported from Japan.
prevalence:
- population: Global
  percentage: Rare
  notes: &gt;-
    Approximately 64-77 cases have been reported worldwide in the published
    literature as of 2022, indicating extreme rarity.
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      A total of 77 patients from 57 articles published between 1967 and 2021
      were included; 59 patients were women. The mean age at diagnosis was 21.2
      years. All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      Systematic review confirms very low global case counts in the published
      literature, supporting classification as a rare disease.
progression:
- phase: Early neuromuscular-dermatologic phase
  age_range: Childhood to young adulthood
  notes: Painful muscle spasms and alopecia are typically initial and universal manifestations.
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      This indicates a consistent early core phenotype across reported cases.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The mean age at diagnosis was 21.2â€‰years.
    explanation: &gt;-
      Average diagnosis in early life supports onset and recognition in childhood
      or young adulthood.
- phase: Multisystem extension phase
  notes: Gastrointestinal, endocrine, growth, and skeletal manifestations accumulate over time.
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      This supports progression from core neuromuscular-dermatologic features to
      broader multisystem disease.
- phase: Severe untreated course
  notes: Without immunomodulatory treatment, progression can lead to major disability or death.
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Clinical course without treatment may result in serious disability or death.
    explanation: &gt;-
      This directly supports severe progression risk in untreated disease.
definitions:
- name: Literature case definition for Satoyoshi syndrome
  definition_type: CASE_DEFINITION
  description: &gt;-
    Case-level definition synthesized from systematic reviews, centered on the
    characteristic triad with multisystem supportive features and autoimmune
    context.
  scope: Published case reports and case series
  criteria_sets:
  - name: Core clinical triad
    description: Characteristic high-yield symptom cluster for case recognition.
    minimum_required: 2
    core_clinical_characteristics:
    - preferred_term: Intermittent painful muscle spasms
      term:
        id: HP:0011964
        label: Intermittent painful muscle spasms
    - preferred_term: Alopecia
      term:
        id: HP:0001596
        label: Alopecia
    - preferred_term: Chronic diarrhea
      term:
        id: HP:0002028
        label: Chronic diarrhea
  - name: Multisystem supportive manifestations
    description: Frequent associated findings that strengthen diagnostic confidence.
    minimum_required: 1
    inclusion_criteria:
    - preferred_term: Malabsorption
      term:
        id: HP:0002024
        label: Malabsorption
    - preferred_term: Secondary amenorrhea
      term:
        id: HP:0000869
        label: Secondary amenorrhea
    - preferred_term: Abnormality of the skeletal system
      term:
        id: HP:0000924
        label: Abnormality of the skeletal system
    exclusion_criteria:
    - preferred_term: Alternative causes of painful muscle spasms and chronic diarrhea excluded
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Its main symptoms are: painful muscle spasms, diarrhea, alopecia and
      skeletal abnormalities.
    explanation: &gt;-
      This supports the core triad-plus-skeletal pattern used for case
      definition.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      Universal occurrence of spasms and alopecia supports high-weight core
      criteria.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      This supports inclusion of multisystem supportive criteria.
pathophysiology:
- name: Systemic Autoimmune Activation
  description: &gt;-
    Satoyoshi syndrome shows systemic immune activation with circulating ANA and
    other autoantibodies in a substantial subset of cases.
  cell_types:
  - preferred_term: Lymphocyte
    term:
      id: CL:0000542
      label: lymphocyte
  - preferred_term: Plasma Cell
    term:
      id: CL:0000786
      label: plasma cell
  biological_processes:
  - preferred_term: B Cell Mediated Immunity
    term:
      id: GO:0019724
      label: B cell mediated immunity
  - preferred_term: Adaptive Immune Response
    term:
      id: GO:0002250
      label: adaptive immune response
  downstream:
  - target: Tissue-Reactive Autoantibody Production
    description: Immune activation yields circulating antibodies against self tissue antigens.
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Antinuclear antibodies were detected in 8 out of 16 cases. Antibodies to
      stomach or duodenum tissue lysates were also detected by Western blot.
    explanation: &gt;-
      Detection of ANA and additional tissue-reactive antibodies supports systemic
      autoimmunity as an upstream disease event.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Autoantibody determinations were performed in 39 patients, of which 27 had
      positive results. The most frequently detected autoantibodies were ANAs.
    explanation: &gt;-
      This broader systematic review confirms frequent autoantibody positivity and
      ANA predominance, reinforcing systemic autoimmune activation.
  - reference: PMID:28940615
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      It is a rare multisystem disorder of presumed autoimmune etiology that is
      characterized by alopecia, intermittent painful muscle spasms, diarrhea, and
      antinuclear antibody positivity.
    explanation: &gt;-
      Independent case-report abstract supports autoimmune etiology and ANA
      positivity in Satoyoshi syndrome.
- name: Tissue-Reactive Autoantibody Production
  description: &gt;-
    Western blot studies identified circulating antibodies that react with brain,
    stomach, and duodenal tissue lysates, consistent with a shared tissue-targeted
    autoimmune response.
  downstream:
  - target: Neuromuscular Circuit Dysfunction
    description: Neural tissue-reactive antibodies are consistent with immune-mediated motor pathway dysfunction.
  - target: Gastrointestinal Mucosal Inflammation
    description: Gastrointestinal tissue-reactive antibodies align with mucosal inflammatory injury.
  - target: Hair Follicle Immune Injury
    description: A systemic tissue-reactive autoimmune profile supports immune targeting of hair follicles.
  evidence:
  - reference: PMID:17405137
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      A common antibody against brain, stomach, and duodenal tissue, according to
      Western blot analysis, was detected in the sera of two patients with this
      syndrome. These findings suggest that Satoyoshi syndrome is a systemic
      autoimmune disease involving the nervous, endocrine, and gastrointestinal
      systems.
    explanation: &gt;-
      This report directly demonstrates tissue-reactive antibodies spanning
      nervous and gastrointestinal systems.
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Antibodies to stomach or duodenum tissue lysates were also detected by
      Western blot.
    explanation: &gt;-
      Independent systematic-review evidence reproduces gastrointestinal
      tissue-reactive antibody detection.
- name: Neuromuscular Circuit Dysfunction
  description: &gt;-
    Immune-mediated dysfunction of motor circuitry and neuromuscular signaling is
    a plausible proximal mechanism for abnormal muscle activation.
  cell_types:
  - preferred_term: Skeletal Muscle Fiber
    term:
      id: CL:0000187
      label: muscle cell
  biological_processes:
  - preferred_term: Regulation of Muscle Contraction
    term:
      id: GO:0006937
      label: regulation of muscle contraction
  - preferred_term: Neuromuscular Transmission
    term:
      id: GO:0007274
      label: neuromuscular synaptic transmission
  downstream:
  - target: Painful Muscle Spasms
    description: Perturbed neuromuscular signaling produces recurrent painful spasms.
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome is a multisystemic rare disease of unknown etiology,
      although an autoimmune basis is presumed. Its main symptoms are: painful
      muscle spasms, diarrhea, alopecia and skeletal abnormalities.
    explanation: &gt;-
      Systematic review of 64 cases confirms painful muscle spasms as a universal
      feature, with autoimmune basis presumed but specific neuromuscular mechanism
      not yet resolved.
  - reference: PMID:16972238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      These findings point to hyperactivity or a disinhibition at the alpha motor
      neuron level, originating probably at that level, although a central origin
      cannot be excluded.
    explanation: &gt;-
      Electrophysiologic data support alpha motor neuron hyperexcitability as a
      proximal mechanism for painful involuntary contractions.
  - reference: PMID:16972238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      During the involuntary contractions, HD-sEMG showed a fourfold increase in
      amplitude compared to maximal voluntary contractions.
    explanation: &gt;-
      Objective EMG amplitude amplification supports abnormal neuromuscular circuit
      excitability as a proximal event.
  - reference: PMID:28215594
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Electroneuromyography showed abnormal spontaneous activity.
    explanation: &gt;-
      Additional electrophysiologic evidence supports neuromuscular hyperexcitability
      as a proximal mechanism.
- name: Gastrointestinal Mucosal Inflammation
  description: &gt;-
    Histology shows predominantly lymphoplasmacytic inflammatory infiltrates
    across the digestive tract.
  cell_types:
  - preferred_term: Lymphocyte
    term:
      id: CL:0000542
      label: lymphocyte
  - preferred_term: Plasma Cell
    term:
      id: CL:0000786
      label: plasma cell
  biological_processes:
  - preferred_term: Inflammatory Response
    term:
      id: GO:0006954
      label: inflammatory response
  downstream:
  - target: Intestinal Absorptive Dysfunction
    description: Persistent mucosal inflammation disrupts nutrient and carbohydrate uptake.
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Histological data revealed predominantly lymphoplasmacytic inflammatory
      infiltrate that can affect any section of the digestive tract.
    explanation: &gt;-
      Histological evidence confirms inflammatory infiltration of the GI tract
      consistent with autoimmune-mediated enteropathy.
  - reference: PMID:17405137
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      We present a patient with this syndrome having a unique &#34;mesh-like&#34; mucosal
      change radiographically and white granules endoscopically in the
      gastrointestinal tract.
    explanation: &gt;-
      Independent endoscopic/radiographic mucosal abnormalities further support GI
      tissue pathology in Satoyoshi syndrome.
- name: Intestinal Absorptive Dysfunction
  description: &gt;-
    Carbohydrate malabsorption is demonstrated by abnormal D-xylose and oral
    glucose tolerance testing.
  biological_processes:
  - preferred_term: Intestinal Absorption
    modifier: DECREASED
    term:
      id: GO:0050892
      label: intestinal absorption
  downstream:
  - target: Malabsorption
    description: Objective absorptive impairment manifests clinically as malabsorption.
  - target: Chronic Diarrhea
    description: Impaired intestinal absorption contributes to persistent diarrhea.
  - target: Short Stature
    description: Chronic malabsorptive disease can impair growth.
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Chronic diarrhea was the main digestive symptom (92.3%). Other symptoms such
      as abdominal pain (15.4%), nausea (7.7%) and vomiting (7.7%), were less
      frequent. The D-xylose test was positive in 10 out of 12 patients, and 9 out
      of 13 cases showed a flattened oral glucose tolerance test suggesting
      carbohydrate malabsorption.
    explanation: &gt;-
      Clinical testing demonstrates carbohydrate malabsorption and its close
      association with chronic diarrhea.
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Chronic diarrhea may be severe and result in malnutrition, anemia, growth
      retardation, cachexia, disability and even death.
    explanation: &gt;-
      This links prolonged gastrointestinal dysfunction to downstream growth
      consequences.
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Chronic diarrhea with malabsorption is one of the most disabling symptoms in
      SS.
    explanation: &gt;-
      This conclusion-level statement directly supports clinically significant
      absorptive dysfunction.
- name: Hair Follicle Immune Injury
  description: &gt;-
    Autoimmune targeting of follicular units is a plausible mechanism for the
    characteristic diffuse hair loss phenotype.
  biological_processes:
  - preferred_term: Immune Response
    term:
      id: GO:0006955
      label: immune response
  downstream:
  - target: Alopecia
    description: Follicular immune injury culminates in diffuse hair loss.
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome is a multisystemic rare disease of unknown etiology,
      although an autoimmune basis is presumed. Its main symptoms are: painful
      muscle spasms, diarrhea, alopecia and skeletal abnormalities.
    explanation: &gt;-
      Systematic review confirms alopecia as one of the main symptoms present in
      100% of reported cases.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      The larger 77-case review confirms alopecia as a universal feature,
      supporting an upstream follicular injury mechanism.
phenotypes:
- name: Painful Muscle Spasms
  category: Musculoskeletal
  frequency: OBLIGATE
  notes: &gt;-
    Progressive, painful intermittent spasms (komuragaeri) especially of limbs and
    trunk; present in 100% of cases
  phenotype_term:
    preferred_term: Intermittent Painful Muscle Spasms
    term:
      id: HP:0011964
      label: Intermittent painful muscle spasms
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome is a multisystemic rare disease of unknown etiology,
      although an autoimmune basis is presumed. Its main symptoms are: painful
      muscle spasms, diarrhea, alopecia and skeletal abnormalities.
    explanation: &gt;-
      Painful muscle spasms are listed as one of the cardinal symptoms in this
      systematic review of 64 cases.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      Independent 77-case review confirms painful spasms as a universal phenotype.
  - reference: PMID:9804090
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome consists of painful intermittent muscle spasms, alopecia and
      diarrhea.
    explanation: &gt;-
      Adult-onset review independently confirms painful intermittent spasms as a
      core phenotype.
- name: Alopecia
  category: Dermatological
  frequency: OBLIGATE
  notes: Alopecia reported in 100% of cases across systematic reviews
  phenotype_term:
    preferred_term: Alopecia
    term:
      id: HP:0001596
      label: Alopecia
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      The largest systematic review (77 cases) reports alopecia as universal in
      Satoyoshi syndrome.
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome is a multisystemic rare disease of unknown etiology,
      although an autoimmune basis is presumed. Its main symptoms are: painful
      muscle spasms, diarrhea, alopecia and skeletal abnormalities.
    explanation: &gt;-
      Independent systematic review (64 cases) also identifies alopecia as a core
      syndrome feature.
- name: Alopecia Universalis
  category: Dermatological
  frequency: FREQUENT
  notes: Universalis subtype reported in approximately 63% of cases
  phenotype_term:
    preferred_term: Alopecia Universalis
    term:
      id: HP:0002289
      label: Alopecia universalis
  evidence:
  - reference: PMID:36930111
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      At the age of 7 years, she developed generalized hair loss and painful
      spasms and was diagnosed with Satoyoshi syndrome.
    explanation: &gt;-
      Case report documents generalized hair loss as a presenting feature of
      Satoyoshi syndrome.
  - reference: PMID:28940615
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      We report an 11-year-old girl with Satoyoshi syndrome who presented to the
      dermatology department for treatment of alopecia universalis.
    explanation: &gt;-
      Case report directly documents alopecia universalis as a presenting phenotype.
- name: Chronic Diarrhea
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  notes: Present in 92.3% of cases with GI involvement; can be fatal
  phenotype_term:
    preferred_term: Chronic Diarrhea
    term:
      id: HP:0002028
      label: Chronic diarrhea
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Chronic diarrhea was the main digestive symptom (92.3%).
    explanation: &gt;-
      Systematic review identifies chronic diarrhea as the predominant GI symptom
      in 92.3% of cases with gastrointestinal manifestations.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      Broader case synthesis also classifies diarrhoea as a frequent Satoyoshi
      manifestation.
  - reference: PMID:28267828
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal
      deformities.
    explanation: &gt;-
      Case history report independently documents chronic diarrhea among multisystem
      Satoyoshi manifestations.
- name: Malabsorption
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  notes: D-xylose and oral glucose tolerance tests demonstrate carbohydrate malabsorption
  phenotype_term:
    preferred_term: Malabsorption
    term:
      id: HP:0002024
      label: Malabsorption
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      The D-xylose test was positive in 10 out of 12 patients, and 9 out of 13
      cases showed a flattened oral glucose tolerance test suggesting carbohydrate
      malabsorption.
    explanation: &gt;-
      Objective malabsorption testing demonstrates carbohydrate malabsorption in
      the majority of tested patients.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      Independent systematic review evidence confirms malabsorption as a frequent
      manifestation.
- name: Amenorrhea
  category: Endocrine
  frequency: VERY_FREQUENT
  notes: Secondary amenorrhea in affected females
  phenotype_term:
    preferred_term: Secondary Amenorrhea
    term:
      id: HP:0000869
      label: Secondary amenorrhea
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      Systematic review of 77 cases identifies amenorrhoea as one of the frequent
      manifestations of Satoyoshi syndrome.
  - reference: PMID:15069249
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome (Komuragaeri disease) is a rare disorder of presumed
      autoimmune etiology, characterized by painful muscle spasms, alopecia,
      diarrhea, endocrinopathy with amenorrhoea and secondary skeletal
      abnormalities.
    explanation: &gt;-
      Independent case report abstract explicitly includes amenorrhoea in the
      characteristic syndrome phenotype.
  - reference: PMID:28267828
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal
      deformities.
    explanation: &gt;-
      Additional case evidence directly supports amenorrhea in Satoyoshi syndrome.
- name: Short Stature
  category: Growth
  frequency: FREQUENT
  notes: Common in pediatric cases, plausibly secondary to malabsorption and chronic inflammation
  phenotype_term:
    preferred_term: Short Stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Chronic diarrhea may be severe and result in malnutrition, anemia, growth
      retardation, cachexia, disability and even death.
    explanation: &gt;-
      Growth retardation is listed as a consequence of severe chronic diarrhea and
      malabsorption in Satoyoshi syndrome.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      Systematic review independently confirms growth retardation as a frequent
      manifestation.
- name: Skeletal Abnormalities
  category: Skeletal
  frequency: FREQUENT
  notes: Skeletal alterations reported in approximately 34% of cases
  phenotype_term:
    preferred_term: Abnormality of the skeletal system
    term:
      id: HP:0000924
      label: Abnormality of the skeletal system
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Its main symptoms are: painful muscle spasms, diarrhea, alopecia and
      skeletal abnormalities.
    explanation: &gt;-
      Skeletal abnormalities are listed as one of the main symptoms in this
      systematic review of 64 cases.
  - reference: PMID:15069249
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome (Komuragaeri disease) is a rare disorder of presumed
      autoimmune etiology, characterized by painful muscle spasms, alopecia,
      diarrhea, endocrinopathy with amenorrhoea and secondary skeletal
      abnormalities.
    explanation: &gt;-
      Independent case literature explicitly reports secondary skeletal
      abnormalities as part of the syndrome.
  - reference: PMID:28267828
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Thereafter, she developed chronic diarrhea, amenorrhea, and skeletal
      deformities.
    explanation: &gt;-
      Independent case evidence supports skeletal deformities as part of the
      phenotype spectrum.
  - reference: PMID:12039433
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      The syndrome consists of the following clinical features: (1) painful,
      intermittent muscle spasms; (2) alopecia; (3) diarrhea; and (4) skeletal
      abnormalities in cases of juvenile onset.
    explanation: &gt;-
      This report explicitly lists skeletal abnormalities as a recognized feature
      in juvenile-onset Satoyoshi syndrome.
- name: Uveitis
  category: Ophthalmologic
  frequency: VERY_RARE
  notes: Newly reported complication (2023); granulomatous pan-uveitis with impending CRVO
  phenotype_term:
    preferred_term: Uveitis
    term:
      id: HP:0000554
      label: Uveitis
  evidence:
  - reference: PMID:36930111
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Unilateral granulomatous pan-uveitis and impending CRVO were observed in
      this patient. Several cases of Satoyoshi syndrome complicated by various
      autoimmune or immunological disorders have been reported. However, to the
      best of our knowledge, no reports of Satoyoshi syndrome presenting with
      uveitis or CRVO have been published. Physicians should consider uveitis as
      a complication of Satoyoshi syndrome.
    explanation: &gt;-
      First reported case of uveitis in Satoyoshi syndrome, expanding the known
      organ spectrum of the disease and supporting systemic autoimmune pathogenesis.
- name: Abdominal Pain
  category: Gastrointestinal
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Abdominal Pain
    term:
      id: HP:0002027
      label: Abdominal pain
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Other symptoms such as abdominal pain (15.4%), nausea (7.7%) and vomiting
      (7.7%), were less frequent.
    explanation: &gt;-
      Abdominal pain reported in 15.4% of cases with gastrointestinal involvement.
histopathology:
- name: Gastrointestinal lymphoplasmacytic inflammatory infiltrate
  description: &gt;-
    Digestive tract histology shows predominantly lymphoplasmacytic inflammatory
    infiltrates, consistent with inflammatory enteropathy.
  frequency: FREQUENT
  diagnostic: false
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Histological data revealed predominantly lymphoplasmacytic inflammatory
      infiltrate that can affect any section of the digestive tract.
    explanation: &gt;-
      This directly supports a characteristic microscopic inflammatory finding in
      Satoyoshi syndrome gastrointestinal disease.
- name: Gastrointestinal mucosal structural abnormalities
  description: &gt;-
    Reported gastrointestinal pathology includes diffuse mucosal structural
    abnormalities seen on radiographic and endoscopic assessment.
  frequency: OCCASIONAL
  diagnostic: false
  evidence:
  - reference: PMID:17405137
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      We present a patient with this syndrome having a unique &#34;mesh-like&#34; mucosal
      change radiographically and white granules endoscopically in the
      gastrointestinal tract.
    explanation: &gt;-
      This supports additional gastrointestinal tissue-level pathology beyond the
      inflammatory infiltrate pattern.
biochemical:
- name: Antinuclear Antibodies (ANA)
  presence: Variable
  context: Most commonly detected autoantibody; found in 8/16 GI-series cases and 21/39 in autoimmunity review
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Antinuclear antibodies were detected in 8 out of 16 cases.
    explanation: &gt;-
      ANA are the most frequently detected autoantibody in Satoyoshi syndrome
      patients.
- name: Anti-Brain and GI Tissue Antibodies
  presence: Positive
  context: Circulating antibodies targeting a ~90 kDa antigen in brain, stomach, and duodenal lysates
  evidence:
  - reference: PMID:17405137
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      A common antibody against brain, stomach, and duodenal tissue, according to
      Western blot analysis, was detected in the sera of two patients with this
      syndrome.
    explanation: &gt;-
      Western blot demonstrates a shared tissue-reactive autoantibody in Satoyoshi
      syndrome sera, supporting a common autoantigen across nervous and
      gastrointestinal systems.
genetic:
- name: No established monogenic etiology
  association: Unknown
  notes: &gt;-
    No single causative gene has been confirmed; current evidence supports a
    probable autoimmune disorder with unresolved molecular etiology.
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Satoyoshi syndrome is a multisystemic rare disease of unknown etiology,
      although an autoimmune basis is presumed.
    explanation: &gt;-
      This review explicitly states that disease etiology remains unknown.
  - reference: PMID:16972238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Although an autoimmune origin of Satoyoshi syndrome seems likely, its exact
      etiology remains as yet unknown, as is the origin of the involuntary
      contractions.
    explanation: &gt;-
      Electrophysiology-focused case study confirms unresolved etiology despite
      autoimmune evidence.
environmental: []
treatments:
- name: Corticosteroids
  description: &gt;-
    First-line treatment with the best overall results. 28 out of 30 cases responded
    to a regimen that included corticosteroids. Corticosteroid-containing regimens
    improved diarrhea in 6 out of 10 patients with GI involvement. None of the
    three patients who died had received corticosteroids or immunosuppressants.
  treatment_term:
    preferred_term: corticosteroid agent therapy
    term:
      id: MAXO:0000640
      label: corticosteroid agent therapy
    qualifiers:
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: prednisone
        term:
          id: CHEBI:8382
          label: prednisone
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: prednisolone
        term:
          id: CHEBI:8378
          label: prednisolone
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      28 out of 30 cases responded to a regimen that included costicosteroids.
    explanation: &gt;-
      Systematic review demonstrates that corticosteroid-containing regimens
      produced favorable responses in the large majority of treated cases.
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      In 6 out of 10 patients, diarrhea improved with a treatment regimen that
      included corticosteroids.
    explanation: &gt;-
      Corticosteroid-containing regimens specifically improved gastrointestinal
      symptoms, supporting the inflammatory/autoimmune basis of the enteropathy.
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      None of the three patients who died had received corticosteroids or
      immunosuppressants.
    explanation: &gt;-
      The observation that all fatal cases lacked immunosuppressive treatment
      suggests corticosteroids may reduce mortality, though publication bias
      must be considered.
- name: Dantrolene
  description: &gt;-
    Muscle relaxant that improved muscle symptoms in 13 out of 15 cases, but did
    not improve any other symptoms of the disease. Used for symptomatic management
    of painful spasms.
  treatment_term:
    preferred_term: skeletal muscle relaxant agent therapy
    term:
      id: MAXO:0000324
      label: skeletal muscle relaxant agent therapy
    qualifiers:
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: dantrolene
        term:
          id: CHEBI:4317
          label: dantrolene
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Dantrolene improved muscle symptoms in 13 out of 15 cases, but not any other
      symptoms of the disease.
    explanation: &gt;-
      Dantrolene is effective for muscle spasm control but does not address the
      underlying autoimmune process or other systemic manifestations.
- name: Immunosuppressive Agents
  description: &gt;-
    Various immunosuppressants including cyclosporine, mycophenolate mofetil,
    azathioprine, methotrexate, tacrolimus, and cyclophosphamide have been used
    as steroid-sparing agents or to improve efficacy of treatment.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: cyclosporine
        term:
          id: CHEBI:4031
          label: cyclosporin A
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: mycophenolate mofetil
        term:
          id: CHEBI:8764
          label: mycophenolate mofetil
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: azathioprine
        term:
          id: CHEBI:2948
          label: azathioprine
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: methotrexate
        term:
          id: CHEBI:44185
          label: methotrexate
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: tacrolimus
        term:
          id: CHEBI:61049
          label: tacrolimus (anhydrous)
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: cyclophosphamide
        term:
          id: CHEBI:4027
          label: cyclophosphamide
  evidence:
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Other immunosuppressive drugs including cyclosporine, mycophenolate mofetil,
      azathioprine, methotrexate, tacrolimus and cyclophosphamide were used to
      decrease corticosteroid dose or improve efficacy.
    explanation: &gt;-
      Multiple immunosuppressive agents have been employed as steroid-sparing
      therapy in Satoyoshi syndrome.
- name: Intravenous Immunoglobulin (IVIG)
  description: &gt;-
    Used in some cases with variable response. Four out of nine patients treated
    with IVIG obtained a favorable response.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: pharmacologic substance
        term:
          id: NCIT:C1909
          label: Pharmacologic Substance
      value:
        preferred_term: human immunoglobulin G
        term:
          id: NCIT:C80829
          label: Human Immunoglobulin G
  evidence:
  - reference: PMID:31217029
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Immunoglobulin therapy was used in nine patients and four of them obtained a
      favorable response.
    explanation: &gt;-
      IVIG produced favorable responses in less than half of treated patients,
      indicating variable efficacy.
epidemiology:
- name: Female proportion among published cases (1967-2021)
  description: Female share in the pooled published-case cohort.
  unit: percentage
  mean_range: &#34;76.6&#34;
  notes: Derived from 59/77 female cases in the 2023 systematic review cohort.
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      A total of 77 patients from 57 articles published between 1967 and 2021
      were included; 59 patients were women.
    explanation: &gt;-
      This supports female predominance among reported Satoyoshi syndrome cases.
- name: Gastrointestinal manifestations among reported Satoyoshi cases (through 2019)
  description: Proportion of reported Satoyoshi cases with gastrointestinal manifestations.
  unit: percentage
  mean_range: &#34;58.2&#34;
  notes: Derived from 39/67 reported cases with GI manifestations.
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Sixty-seven cases of SS were found up until December 2019. Thirty-nine
      cases described gastrointestinal manifestations.
    explanation: &gt;-
      This provides the denominator and numerator for GI-manifestation proportion
      among reported Satoyoshi cases.
- name: Chronic diarrhea among Satoyoshi cases with gastrointestinal manifestations
  description: Proportion of chronic diarrhea within the GI-manifesting Satoyoshi subset.
  unit: percentage
  mean_range: &#34;92.3&#34;
  notes: Proportion within GI-involved Satoyoshi case subset.
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Chronic diarrhea was the main digestive symptom (92.3%).
    explanation: &gt;-
      This gives a percentage-based epidemiologic estimate for chronic diarrhea in
      GI-manifesting Satoyoshi syndrome.
- name: Mean age at diagnosis in published cases
  description: Mean age at diagnosis from systematic review case aggregation.
  unit: years
  mean_range: &#34;21.2&#34;
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The mean age at diagnosis was 21.2â€‰years.
    explanation: &gt;-
      This provides a pooled central estimate of diagnostic age in published
      Satoyoshi syndrome cases.
- name: Autoantibody positivity among tested cases
  description: Fraction of patients with at least one positive autoantibody among those tested.
  unit: proportion
  mean_range: &#34;27/39&#34;
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Autoantibody determinations were performed in 39 patients, of which 27 had
      positive results.
    explanation: &gt;-
      This quantifies the high serologic autoimmunity burden in reported cases.
diagnosis:
- name: Clinical pattern recognition
  presence: Characteristic multisystem constellation
  description: &gt;-
    Diagnosis is primarily clinical, based on the combination of painful muscle
    spasms and alopecia with frequent gastrointestinal and skeletal/endocrine
    features.
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      All cases had painful muscular spasms and alopecia.
    explanation: &gt;-
      Universal co-occurrence of these two manifestations supports their central
      diagnostic importance.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Frequent manifestations included: diarrhoea, malabsorption, growth
      retardation, amenorrhoea and bone deformity.
    explanation: &gt;-
      Frequent multisystem manifestations further define the recognizable clinical
      syndrome.
- name: Autoantibody assessment
  presence: Frequently positive
  markers: ANA and less frequently anti-acetylcholine receptor, anti-DNA, antithyroid, anti-GAD, and antigliadin antibodies
  evidence:
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Autoantibody determinations were performed in 39 patients, of which 27 had
      positive results.
    explanation: &gt;-
      High frequency of positive autoantibodies supports routine serologic
      autoimmune evaluation.
  - reference: PMID:36749015
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      The most frequently detected autoantibodies were ANAs. Other less frequently
      found autoantibodies were: anti-acetylcholine receptor antibodies, anti-DNA
      antibodies, antithyroid antibodies, anti-glutamic acid decarboxylase
      (anti-GAD) and anti-gliadin antibodies.
    explanation: &gt;-
      This identifies the most informative autoantibody panel components reported
      in the literature.
- name: Gastrointestinal malabsorption testing
  presence: Frequently abnormal in patients with digestive involvement
  results: D-xylose and oral glucose tolerance test abnormalities consistent with carbohydrate malabsorption
  evidence:
  - reference: PMID:32429959
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      The D-xylose test was positive in 10 out of 12 patients, and 9 out of 13
      cases showed a flattened oral glucose tolerance test suggesting carbohydrate
      malabsorption.
    explanation: &gt;-
      Objective absorptive testing provides supportive diagnostic evidence for the
      gastrointestinal component.
- name: Surface electromyography during spasms
  presence: Abnormal
  description: &gt;-
    Surface EMG can document high-amplitude involuntary contractions and support
    motor hyperexcitability physiology.
  evidence:
  - reference: PMID:16972238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      During the involuntary contractions, HD-sEMG showed a fourfold increase in
      amplitude compared to maximal voluntary contractions.
    explanation: &gt;-
      Electrophysiology directly captures abnormal motor activity during painful
      contractions.
- name: Tissue-reactive antibody Western blot (research support)
  presence: Reported positive
  description: Western blot reactivity to brain and gastrointestinal tissue lysates has been reported in Satoyoshi syndrome sera.
  evidence:
  - reference: PMID:17405137
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      A common antibody against brain, stomach, and duodenal tissue, according to
      Western blot analysis, was detected in the sera of two patients with this
      syndrome.
    explanation: &gt;-
      Tissue-reactive antibody detection supports the autoimmune diagnosis model.
differential_diagnoses:
- name: Classic stiff person syndrome
  description: &gt;-
    Both disorders can present with painful muscle spasms, but classic stiff
    person syndrome is defined by prominent persistent body stiffness and
    characteristic axial involvement.
  disease_term:
    preferred_term: classic stiff person syndrome
    term:
      id: MONDO:0018625
      label: classic stiff person syndrome
  distinguishing_features:
  - Typical SPS presentation includes generalized body stiffness and exaggerated lumbar lordosis.
  - Satoyoshi syndrome instead has obligate alopecia and frequent chronic diarrhea/malabsorption.
  evidence:
  - reference: PMID:23186907
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      It is uncommon, characterized by body stiffness associated with painful
      muscle spasms, and varies in location and severity.
    explanation: &gt;-
      Confirms the painful spasm overlap and defining stiffness phenotype of SPS.
  - reference: PMID:23186907
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Most patients demonstrate exaggerated lumbar lordosis.
    explanation: &gt;-
      Lumbar lordosis is a characteristic SPS feature that helps distinguish it
      from Satoyoshi syndrome.
  - reference: PMID:31217029
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Its main symptoms are: painful muscle spasms, diarrhea, alopecia and
      skeletal abnormalities.
    explanation: &gt;-
      Satoyoshi-specific multisystem features (especially alopecia and diarrhea)
      help distinguish it from SPS.
- name: Isaac syndrome
  description: &gt;-
    Both disorders can involve painful cramps/spasms, but Isaac syndrome is a
    peripheral nerve hyperexcitability disorder with continuous motor activity
    and characteristic myokymia/fasciculations.
  disease_term:
    preferred_term: Isaac syndrome
    term:
      id: MONDO:0019399
      label: Isaac syndrome
  distinguishing_features:
  - Continuous motor activity with fasciculations and myokymia suggests Isaac syndrome.
  - Electrodiagnostic after-discharges and neuromyotonic/myokymic discharges are typical for Isaac syndrome.
  evidence:
  - reference: PMID:25736532
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Isaacs syndrome is a peripheral nerve hyperexcitability (PNH) syndrome that
      presents as continuous motor activity. Clinical findings include cramps,
      fasciculations, and myokymia.
    explanation: &gt;-
      This defines key clinical features that separate Isaac syndrome from the
      broader multisystem Satoyoshi phenotype.
  - reference: PMID:25736532
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &gt;-
      Electrodiagnosis plays a key role in diagnosis by demonstrating
      after-discharges on nerve conduction studies, and fasciculation potentials,
      myokymic discharges, neuromyotonic discharges, and other types of abnormal
      spontaneous activity on needle examination.
    explanation: &gt;-
      Characteristic electrodiagnostic findings provide a key differentiator from
      Satoyoshi syndrome.
animal_models: []
clinical_trials: []
datasets: []
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Satoyoshi_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>